Author:
Shi Joy,Swanson Sonja A.,Kraft Peter,Rosner Bernard,De Vivo Immaculata,Hernán Miguel A.
Abstract
Abstract
Background
In many applications of instrumental variable (IV) methods, the treatments of interest are intrinsically time-varying and outcomes of interest are failure time outcomes. A common example is Mendelian randomization (MR), which uses genetic variants as proposed IVs. In this article, we present a novel application of g-estimation of structural nested cumulative failure models (SNCFTMs), which can accommodate multiple measures of a time-varying treatment when modelling a failure time outcome in an IV analysis.
Methods
A SNCFTM models the ratio of two conditional mean counterfactual outcomes at time k under two treatment strategies which differ only at an earlier time m. These models can be extended to accommodate inverse probability of censoring weights, and can be applied to case-control data. We also describe how the g-estimates of the SNCFTM parameters can be used to calculate marginal cumulative risks under nondynamic treatment strategies. We examine the performance of this method using simulated data, and present an application of these models by conducting an MR study of alcohol intake and endometrial cancer using longitudinal observational data from the Nurses’ Health Study.
Results
Our simulations found that estimates from SNCFTMs which used an IV approach were similar to those obtained from SNCFTMs which adjusted for confounders, and similar to those obtained from the g-formula approach when the outcome was rare. In our data application, the cumulative risk of endometrial cancer from age 45 to age 72 under the “never drink” strategy (4.0%) was similar to that under the “always ½ drink per day” strategy (4.3%).
Conclusions
SNCFTMs can be used to conduct MR and other IV analyses with time-varying treatments and failure time outcomes.
Publisher
Springer Science and Business Media LLC
Subject
Health Informatics,Epidemiology
Reference21 articles.
1. Hernán MA, Robins JM. Instruments for causal inference: An epidemiologist’s dream? Epidemiology. 2006;17(4):360–372. Available from: https://pubmed.ncbi.nlm.nih.gov/16755261/ [cited 30 Sep 2020]
2. Swanson SA, Tiemeier H, Ikram MA, Hernán MA. Nature as a Trialist?: deconstructing the analogy between Mendelian randomization and randomized trials. Epidemiology. 2017;28(5):653–9.
3. Smith GD, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23(R1):R89–R98.
4. Burgess S, Small DS, Thompson SG. A review of instrumental variable estimators for Mendelian randomization. Stat Methods Med Res. 2017;26(5):2333–2355. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26282889 [cited 15 Nov 2019].
5. Shi J, Swanson SA, Kraft P, Rosner B, De Vivo I, Hernán MA. Mendelian randomization with repeated measures of a time-varying exposure: an application of structural mean models. Epidemiology. In Press.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献